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LRP1 influences trafficking of 
N-type calcium channels via 
interaction with the auxiliary α2δ-1 
subunit
Ivan Kadurin, Simon W. Rothwell, Beatrice Lana, Manuela Nieto-Rostro & Annette C. Dolphin
Voltage-gated Ca2+ (CaV) channels consist of a pore-forming α1 subunit, which determines the main 
functional and pharmacological attributes of the channel. The CaV1 and CaV2 channels are associated 
with auxiliary β- and α2δ-subunits. The molecular mechanisms involved in α2δ subunit trafficking, and 
the effect of α2δ subunits on trafficking calcium channel complexes remain poorly understood. Here we 
show that α2δ-1 is a ligand for the Low Density Lipoprotein (LDL) Receptor-related Protein-1 (LRP1), a 
multifunctional receptor which mediates trafficking of cargoes. This interaction with LRP1 is direct, and 
is modulated by the LRP chaperone, Receptor-Associated Protein (RAP). LRP1 regulates α2δ binding to 
gabapentin, and influences calcium channel trafficking and function. Whereas LRP1 alone reduces α2δ-1 
trafficking to the cell-surface, the LRP1/RAP combination enhances mature glycosylation, proteolytic 
processing and cell-surface expression of α2δ-1, and also increase plasma-membrane expression and 
function of CaV2.2 when co-expressed with α2δ-1. Furthermore RAP alone produced a small increase in 
cell-surface expression of CaV2.2, α2δ-1 and the associated calcium currents. It is likely to be interacting 
with an endogenous member of the LDL receptor family to have these effects. Our findings now provide 
a key insight and new tools to investigate the trafficking of calcium channel α2δ subunits.
Voltage-gated Ca2+ (CaV) channels are multi-subunit complexes, containing a pore-forming α 1 subunit, which 
determines the main functional and pharmacological attributes of the channel1. The high voltage-activated CaV1 
and CaV2 α 1 subunits are associated with two auxiliary subunits, both of which affect the trafficking and proper-
ties of these channels. The intracellular β subunit binds to the channels in the endoplasmic reticulum (ER), and 
protects the channel from ER-associated degradation2,3. In contrast, the mechanism by which the α 2δ subunit 
enhances the functional expression of the channel complex is less well understood4,5.
Genes encoding four α 2δ subunits have been identified (for review see ref. 6). We have shown that α 2δ subunits 
are glycosylphosphatidylinositol (GPI)-anchored proteins7, which accumulate in detergent-resistant microdo-
mains (DRMs), also termed lipid rafts7,8. This is confirmed for α 2δ -1 in the recent high resolution structure of 
CaV1.19. We have also shown the Von Willebrand Factor A (VWA) domain of α 2δ subunits to be crucial for the 
trafficking of the associated α 1 subunits to the plasma membrane4, and for their ability to increase calcium cur-
rents and transmitter release4,10.
Both α 2δ -1 and α 2δ -2 bind to the anti-epileptic and anti-hyperalgesic drugs gabapentin and pregabalin8,11. 
Indeed, binding to α 2δ -1 is essential for the therapeutic effect of these drugs in the alleviation of neuropathic 
pain12. We have shown that chronic application of gabapentinoids suppresses calcium currents by inhibiting α 2δ -1 
and α 2δ -2 trafficking, and have proposed this as the mechanism of action of these drugs13–15.
Identification of the molecular mechanisms that control the trafficking of α 2δ subunits is central to under-
standing their diverse roles in the regulation of Cavα 1 subunit plasma membrane localization5, in synaptic trans-
mission10,16,17, as mediators of the therapeutic effects of the gabapentinoid drugs12, and in relation to their novel 
roles in synaptic function5,18,19.
Using bungarotoxin binding site (BBS)-tagged α 2δ -2, we have previously observed constitutive endocytosis 
and recycling of the α 2δ -2 subunit from recycling endosomes, in a rab11-dependent manner13. Since α 2δ subunits 
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are GPI-anchored7,9, these results invoke the existence of an adaptor protein to bridge the interaction between 
α 2δ subunits and intracellular trafficking pathways.
Low density lipoprotein (LDL) receptor-related protein-1 (LRP1) is a member of a large LDL receptor family20, 
which also includes LDL receptor, very low density lipoprotein receptor, apoE receptor 2, glycoprotein 330 
(gp330/megalin/LRP2) and LRP1B21. In addition, this protein family comprises LRP5, and LRP6, which are 
involved in Wnt signalling22. LRP1 is multifunctional receptor, interacting with number of protein ligands, most 
of which bind to the four clusters of cysteine-rich and EGF- repeats, termed ligand binding domains (LBDs). It 
mediates both forward trafficking and endocytosis of protein cargoes21. Binding of LRP1 ligands at the plasma 
membrane can also promote its assembly into co-receptor systems and initiate intracellular cell signaling 
cascades23.
We surmised that LRP1 would be a good candidate for a role in trafficking the α 2δ subunits, since it is involved 
in forward trafficking of a number of other proteins, including β 1-integrin24 and GPI-anchored PrP25, and in 
clathrin-dependent endocytosis21,26. It is also involved in the trafficking of glucose transporter-4, which is rapidly 
inserted into the plasma membrane from sub-membrane storage vesicles in response to insulin27. In the nervous 
system, LRP1 is present in synapses28, as is α 2δ -115, and neuronal deletion of the LRP1 gene results in a phenotype 
including neurodegeneration and synapse loss, and development of behavioral and motor abnormalities29,30. The 
interaction of LRP1 with specific ligands has also been implicated in neurite outgrowth31. LRP1 has also been 
shown to bind to thrombospondins with high affinity32, which is implicated in synapse formation19, and is able to 
bind more than one ligand at different sites33.
LRP1 and related proteins interact with Receptor-Associated Protein (RAP), a 39 kDa specific chaperone pro-
tein resident in the ER, which prevents interaction of LRP1 with its ligands until they reach the Golgi34. The 
relatively acidic lumenal environment of the Golgi causes protonation of key histidine residues, and a structural 
rearrangement ‘histidine switch’ of RAP, which leads to its dissociation from LRP135. RAP has been shown to be 
about 2-fold down-regulated in dorsal root ganglion (DRG) neurons following nerve injury36, suggesting that 
the interaction of LRP1 (and other family members) with their ligands might be dynamically regulated by the 
availability of RAP.
In the present study we show that α 2δ -1 is a ligand for LRP1, and their interaction is modulated by RAP. This 
interaction regulates the trafficking, post-translational processing, and function of α 2δ -1 as a calcium channel 
subunit. Our findings now provide a key insight and new tools to investigate the trafficking and function of the 
calcium channel α 2δ subunits.
Results
Interaction between LRP1 and α2δ subunits. We first examined whether LRP1 is able to interact with 
α 2δ -1 subunits. LRP1 is a 600 kDa pro-protein that is cleaved by the Golgi-associated protease furin into an 
~85 kDa light-chain and a ~515 kDa heavy-chain; the two polypeptides remaining non-covalently-associated. 
The heavy-chain contains four homologous LBDs, which were identified to mediate binding to most of the LRP1 
interacting proteins37,38. Each domain can be expressed independently, fused with the common 85 kDa trans-
membrane domain39. These are termed mini-receptors (LRP1-m1–m4), and have been shown to mimic the effect 
of full-length LRP138,39. Most of the data obtained here involves experiments with a construct consisting of the 
fourth LBD of LRP1 (LRP1-m4).
The LRP1 mini-receptors were transiently expressed together with α 2δ -1 in tsA-201 cells. In preliminary 
studies, we found LRP1 mini-receptors containing LBDs 2, 3 and 4 (HA-tagged LRP1-m2, -m3 and -m4) all 
co-immunoprecipitate with α 2δ -1, whereas HA-LRP1-m1 showed less co-immunoprecipitation, as has also been 
found for other LRP1 ligands39. Figure 1a shows α 2δ -1 interaction with HA-LRP1-m2 and HA-LRP1-m4 (data 
with HA-LRP1-m1 and -m3 not shown). We also co-expressed Flag-tagged LRP1-m4 together with HA-tagged 
α 2δ -1 (HA-α 2δ -1), and we used either anti-HA or anti-Flag antibodies on beads for pulldown. In both cases 
reciprocal co-immunoprecipitation was observed. Figure 1b shows immunoprecipitation of Flag-LRP1-m4 
and co-immunoprecipitation of HA-α 2δ -1. As expected, the reciprocal immunoprecipitation of HA-α 2δ -1 also 
co-immunoprecipitated Flag-LRP1-m4 (data not shown). As a positive control for the co-immunoprecipitation 
we used Prion protein (PrP), which has previously been shown to interact with LRP125 (data not shown). We have 
previously used the same constructs to demonstrate co-immunoprecipitation with another known LRP1 ligand, 
thrombospondin-440.
Interaction between α2δ-1 and LRP1-m4 is reduced by RAP. The ER-resident chaperone RAP binds 
at multiple sites on LRP1, and has a dual role. It antagonises premature binding of LRP1 with its ligands in the ER 
and also promotes LRP1 folding and trafficking to the Golgi where ligand interaction occurs41. Premature binding 
to LRP1 in the ER was reported for other known LRP1 ligands and is considered to be a general property of LRP142. 
The interaction of α 2δ -1 with LRP1-m4 was significantly reduced, but not prevented, by co-expression of RAP 
(Fig. 1b, compare lane 1 with lanes 2 and 3 in the right upper panels, quantified in Fig. 1c). The amount of RAP 
used (1 μ g cDNA) was likely to be saturating, as doubling the amount of cDNA had no additional effect (Fig. 1b, 
compare lanes 2, and 3, quantification in Fig. 1c). Similar results were obtained with LRP1-m2 (data not shown), 
demonstrating that α 2δ -1 binds indiscriminately to LBDs 2 and 4. As a negative control, instead of RAP we trans-
fected the cells with GFP (Fig. 1b; lane 1; Fig. 1c), which demonstrated that the effect of RAP on the interaction 
is specific and it is not due to reduced protein expression. Thus the continuing interaction of LRP1-m2 and -m4 
with α 2δ -1 when RAP is co-expressed is likely to represent an interaction that is relevant to α 2δ -1 trafficking.
Interaction with LRP1 reduces the binding of gabapentin to α2δ subunits. We then examined the 
effect of LRP1-m4 co-expression on [3H]-gabapentin binding to α 2δ -1. LRP1-m4 and RAP were co-expressed 
with α 2δ -1 in tsA-201 cells. Saturation binding experiments analysing the binding of [3H]-gabapentin to 
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membranes from cells expressing α 2δ -1 and α 2δ -1/LRP1-m4 demonstrate that LRP1-m4 does not alter the gab-
apentin binding affinity to α 2δ -1 (Fig. 1d). The KD for α 2δ -1 alone was 180.2 ± 23.0 nM, and for α 2δ -1/LRP1-m4 
it was 230.0 ± 53.0 nM (n = 6, P > 0.05). In contrast, the presence of LRP1-m4 resulted in a 38% decrease in the 
measured Bmax for [3H]-gabapentin binding to α 2δ -1 from 3.63 ± 0.56 pmol/mg protein, to 2.06 ± 0.52 pmol/mg 
protein when LRP1-m4 was co-expressed with α 2δ -1 (n = 6, P = 0.0129). This suggests that when α 2δ -1 interacts 
with LRP1-m4, the association may occlude the gabapentin binding site.
α2δ-1 and LRP1-m4 bind in vitro. Further evidence for the interaction between α 2δ -1 and LRP1-m4 was 
obtained from in vitro interaction experiments. Lysates from tsA-201 cells expressing HA-α 2δ -1 were applied 
either to beads loaded with pre-bound Flag-LRP1-m4, or to control beads pre-incubated with WCL from 
untransfected cells under identical conditions (Fig. 2a). After washing, HA-α 2δ -1 was found attached to LRP1-m4 
containing beads, but not to control beads (Fig. 2b, lane 3).
LRP1-m4 and α2δ-1 are associated on the cell surface in the presence of RAP. Since an inter-
action between α 2δ -1 and LRP1-m4 is maintained in the presence of RAP (Fig. 1b,c), we hypothesised that the 
two proteins may remain associated on the cell surface. To test this, we applied Flag antibody to intact tsA-201 
cells transfected with α 2δ -1 and either Flag-LRP1-m4 or HA-LRP1-m4, with or without RAP; then incubated 
cells at 4 °C to prevent endocytosis, and immunoprecipitated Flag-LRP1-m4, following cell lysis. We found more 
immunoprecipitation of LRP1-m4 from the cell surface in the presence of co-transfected RAP, than in its absence 
Figure 1. LRP1-m4 interaction with α2δ-1 is decreased by RAP. (a) tsA-201 cells were transfected with α 2δ -1 
(lanes 1–3), alone or with HA-LRP1-m2 (lane 2) or HA-LRP1-m4 (lane 3). Western blots showing: left panels, 
WCL; right panels, immunoprecipitate (IP) with HA Ab. Top panels: Western blot against α 2δ -1 (α 2δ -1 mAb), 
bottom panels: western blot against HA for HA-LRP1-m2 or -m4. The IP western blot has been stripped from α 
2δ -1 mAb and reblotted against HA. Samples were not deglycosylated. (b) tsA-201 cells transfected with  
HA-α 2δ -1 and Flag-LRP1-m4 (lanes 1–3), without RAP (lane 1) or co-transfected with 1 μ g or 2 μ g RAP  
(lanes 2 and 3). CaV2.2 and β 1b were co-transfected in all conditions. Samples were not deglycosylated. Left 
panels: Input WCL; right panels, co-IP with anti-Flag Ab. Top panels: HA-α 2δ -1 (HA Ab), middle panels:  
Flag-LRP1-m4 (Flag Ab), lower panels: RAP reblot (anti-LRP1/RAP Ab), and anti-Akt loading control.  
(c) Quantification of co-IP measured as a ratio of the HA-α 2δ -1 bands in the co-IP, relative to the input WCL 
(including experiment shown in (b)), in the presence of Flag-LRP1-m4, and in the absence (black bar) or 
presence of the two concentrations of RAP shown in (b) (blue and red bars). Mean ± SEM and individual data 
for n = 3 experiments, each normalised to the control in the absence of RAP. *** P < 0.001, 1-way ANOVA and 
Bonferroni’s post-hoc test. (d) [3H]-gabapentin binding curves, using membrane fractions from transfected 
tsA-201 cells, for binding to α 2δ -1 (open squares, n = 6) and α 2δ -1 + LRP1-m4 + RAP (black circles, n = 6). 
Mean ± SEM data were fit by the Hill equation: KD = 229.5 and 213.7 nM, respectively. Bmax = 4.02 and 1.76 
pmol/mg protein, respectively. Full blots for all figure parts are shown in Supplementary information.
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(Fig. 2c, lower panel, lane 4 compared to lane 3). We also found that α 2δ -1 co-immunoprecipitated with cell sur-
face Flag-LRP1-m4, only in cells co-transfected with LRP1-m4 and RAP, and was not detectable without RAP 
(Fig. 2c, lower panel, lane 4 compared to lane 3). This also agrees with one of the main roles of RAP being to 
promote folding and trafficking of LRP1 and its ligands to the cell surface.
LRP1 binds anchorless α2δ-1ΔC in vitro. We then utilised a soluble anchorless α 2δ -1 construct 
(α 2δ -1Δ C, Fig. 3a), which is truncated prior to the C-terminus so that it is not GPI-anchored, and has previously 
been characterized to be in part secreted as a soluble protein43. We found, using a dot blot technique previously 
employed to demonstrate interactions with LRP144, that soluble α 2δ -1Δ C-HA protein purified from conditioned 
medium (Fig. 3b; arrow) and purified soluble LRP1-m2 LBD protein immobilised on nitrocellulose membrane 
(Fig. 3c), interact in vitro, as shown by the staining for α 2δ -1Δ C-HA (Fig. 3d; left panel). An identical amount of 
bovine serum albumin (BSA) protein immobilised on the same membrane adjacent to LRP1-m2 did not bind to 
α 2δ -1Δ C-HA, demonstrating the specificity of the interaction (Fig. 3d; left panel). As an additional control, mem-
branes with immobilised BSA and LRP1-m2 LBD were treated under identical conditions except α 2δ -1Δ C-HA 
was omitted, and the HA antibody signal was lost, showing that it is due to specific labelling of α 2δ -1Δ C-HA by 
this antibody (Fig. 3d; right panel). Moreover, the interaction was dependent on structural features of LRP1-m2 
LBD, because denaturation of the protein prior to its immobilisation on the membrane resulted in a decrease of 
the interaction with α 2δ -1Δ C-HA (compare Fig. 3e with the left panel of Fig. 3d).
Figure 2. LRP1-m4 and α2δ-1 interact in vitro. (a) Western blot analysis of Flag-LRP1-m4 interaction 
with HA-α 2δ -1. Samples were not deglycosylated. The top panels show aliquots from WCL prepared from 
untransfected- or Flag-LRP1-m4 and RAP-transfected tsA-201 cells (upper panel: Flag Ab), which were 
then applied to anti-Flag-agarose beads overnight to precipitate Flag-LRP1-m4. An aliquot of the beads with 
precipitated material was eluted to show bound Flag-LRP1-m4 (lower panel: Flag Ab). The remaining beads 
with pre-bound Flag-LRP1-m4 were used for the in vitro binding assay. (b) Lane 1 in top (anti-α 2δ -1) and 
bottom (anti–HA) western blot panels corresponds to aliquots of the WCL from HA-α 2δ -1 transfected tsA-
201 cells, which were applied to beads with pre-bound Flag-LRP1-m4 (lane 3 in (b), equivalent to lane 2 in 
(a)), or untransfected cells (lane 2 in (b), equivalent to lane 1 in (a)). Arrows on right indicate α 2δ -1 binding. 
(c) Cell surface co-IP from tsA-201 cells expressing HA-α 2δ -1 without (lane 1) or with HA-LRP1-m4 (lane 2) 
or Flag-LRP1-m4 (lanes 3, 4), with or without RAP, as indicated, analysed by western blot. Samples were not 
deglycosylated. WCL input (top); cell surface co-IP with Flag Ab (bottom). For both WCL and IP: top panel: 
HA-α 2δ -1 (α 2δ -1 Ab); middle panel: Flag-LRP1-m4 (Flag Ab); bottom panel: samples ran on separate gel and 
reblotted against GAPDH loading control and control for cell surface IP. Representative of n = 3 experiments. 
Full blots for all figure parts are shown in Supplementary information.
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Interaction between endogenous LRP1 and α2δ-1 in DRMs. Both α 2δ proteins7,8 and PrP45 are 
GPI-anchored DRM-associated proteins, and both interact with LRP1. We therefore performed experiments 
using material from mouse brain, and found some LRP1 in DRMs from WT mouse brain, although most was in 
the soluble fractions (Fig. 4a, left top panel, white arrow). The same was true for RAP (Fig. 4a, bottom panels). 
Therefore, since most endogenous α 2δ -1 is present in DRMs (Fig. 4a, left second panel, white arrow), we decided 
to use mouse brain DRMs as the input, to attempt to co-immunoprecipitate native α 2δ -1 with LRP1. As controls, 
brains from α 2δ -1−/− mice were included (Fig. 4a, right panels), as well as control immunoprecipitation with an 
irrelevant IgG, and also co-immunoprecipitation of the known LRP1 ligand PrP. LRP1 was immunoprecipitated 
with LRP1 Ab (Fig. 4b; top right panel, lanes 2 and 4).
The small amount of LRP1 in DRMs co-immunoprecipitated with a correspondingly small fraction of 
the total α 2δ -1 in DRMs from α 2δ -1+/+ mice (Fig. 4b; middle panel, lane 4). As a control, α 2δ -1 was not 
co-immunoprecipitated with an irrelevant IgG (Fig. 4b; middle panel, lane 3), or in identical experiments using 
α 2δ -1−/− brain DRMs (Fig. 4b; middle panel, lanes 1 and 2). A similarly small fraction of PrP, relative to the total 
PrP that localised to DRMs, was co-immunoprecipited with LRP1 in parallel (Fig. 4b, bottom panel, lanes 2 and 4), 
which is again in line with the minor localisation of LRP1 in DRMs.
RAP increases the cell surface expression of α2δ-1 in the presence of LRP1-m4. In agreement 
with the cell surface co-immunoprecipitation results shown in Fig. 2c, cell surface biotinylation experiments pro-
vided evidence that RAP markedly increased the amount of α 2δ -1 on the cell surface in the presence of LRP1-m4 
(Fig. 5a, upper right panel, lane 3 compared to lane 2; quantified in Fig. 5b). As shown previously39, the pro-
cessing and surface expression of LRP1-m4 were increased in the presence of RAP, demonstrating its effects on 
the trafficking of LRP1 itself (Fig. 5a, compare lanes 2 and 3 in the bottom right panel). We also examined the 
cell-surface expression of a non-functional α 2δ -1 construct with mutations in the metal ion-dependent adhe-
sion site (MIDAS) motif of the VWA domain (α 2δ -1-MIDASAAA)4,10. We have previously shown that this mutant 
demonstrates reduced cell surface expression, compared to WT α 2δ -146. We found here that plasma membrane 
expression of this mutant is not increased by co-expression of LRP1-m4 and RAP, unlike WT α 2δ -1 (Fig. 5c, right 
panel; quantified in Fig. 5d). This suggests that during its trafficking α 2δ -1 may require an intact VWA domain to 
be affected by LRP1.
Furthermore, in agreement with the cell surface biotinylation results, when tsA-201 cells were transfected with 
HA-α 2δ -1 and LRP1-m4, with or without RAP, cell surface expression of HA-α 2δ -1, detected immunocytochem-
ically, was also increased by the presence of RAP (Fig. 5e, quantified in Fig. 5f).
RAP increases secretion of anchorless α2δ-1ΔC in the presence of LRP1-m4. Secretion of 
C-terminally truncated soluble LRP1 constructs has been used previously to study the role of the interaction of 
RAP with LRP147. In order to determine whether membrane anchoring of α 2δ -1 was required for its interaction 
Figure 3. Purified α2δ-1ΔC binds to purified LRP1-m2, but not to BSA immobilised by dot blot on 
nitrocellulose membranes. (a) Cartoon showing α 2δ -1Δ C construct with a C-terminal HA tag (middle and 
bottom) in place of the GPI anchor signal sequence present in WT α 2δ -1 (top). (b) α 2δ -1Δ C-HA affinity-
purified on an HA-agarose-column from conditioned medium of transfected tsA-201 cells, visualised by 
western blot with HA Ab (left). Right: silver stain of the gel with the same material showing α 2δ -1Δ C-HA 
(MW ~165 kDa) and an unspecific band (*; ~70 kDa). (c) LRP1-m2 LBD (0.2 μ g, left) or BSA (0.2 μ g, right) 
were immobilised on a nitrocellulose membrane and the protein was visualised by anti-LRP1 Ab. (d) LRP1-m2 
LBD (0.2 μ g) or BSA (0.2 μ g) were immobilised on nitrocellulose membranes and incubated with either 50 nM 
purified α 2δ -1Δ C-HA (left panel), or vehicle buffer (right panel), followed by visualisation of the bound α 2δ -1Δ 
C-HA with anti-HA Ab, as described in Methods. Representative of n = 3. (e) The structure of LRP1 LBDs is 
crucial for ligand binding, as pre-treatment of purified LRP1-m2 LBD in buffer with 2% SDS and 100 mM DTT, 
to denature the protein and disrupt disulphide bonds (LRP1-m2 LBD*), resulted in less α 2δ -1Δ C-HA binding. 
Full blots for all figure parts are shown in Supplementary information.
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with LRP1, we utilised the anchorless α 2δ -1 construct described above (α 2δ -1Δ C, cartoon in Fig. 3a), which 
can be secreted as a soluble protein43. We studied the effect of LRP1-m4 and the role of RAP on the secretion of 
α 2δ -1Δ C into the medium. When we co-expressed α 2δ -1Δ C with increasing concentrations of RAP, we found 
that secretion of α 2δ -1Δ C was increased compared to the control in the absence of RAP (Fig. 6a, lanes 3–5 
compared to lane 2, quantified in Fig. 6b). Furthermore, RAP also antagonised the inhibitory effect of LRP1-m4 
on α 2δ -1Δ C secretion (Fig. 6a, lane 7 compared to lane 6, quantified in Fig. 6b). This result shows that RAP 
antagonised the interaction of α 2δ -1Δ C with both exogenous LRP1-m4 and also endogenous LRP1 (or related 
endogenous members of the LDL-receptor family), to promote secretion of α 2δ -1Δ C.
We have previously found that while most is secreted, some α 2δ -1Δ C remains associated with the cell surface 
of tsA-201 cells and DRG neurons by non-covalent interactions, and we speculated that another molecular inter-
actor mediates this cell-surface association, in the absence of GPI-anchoring43. In the light of the interaction with 
LRP1 identified here, and the modulatory role of RAP in this interaction, we decided to investigate the effect of 
RAP on the cell surface association of α 2δ -1Δ C. Co-expression of RAP with α 2δ -1Δ C in tsA-201 cells strikingly 
reduced the amount of α 2δ -1Δ C on the cell surface, as measured by cell surface immunofluorescence, compared 
Figure 4. Localization and co-immunoprecipitation of α2δ-1 and LRP1 in DRMs. (a) Sucrose gradient 
fractions prepared from α 2δ -1+/+ (left panel) and α 2δ -1−/− mouse brain (right panel), showing that LRP1 was 
mainly concentrated in the detergent-soluble fractions (top panel, lanes 11–13), although a small proportion 
of LRP1 is present in DRM fraction 5 (white arrow); whereas α 2δ -1 is concentrated in DRM fraction 5 (second 
panel; left, white arrow), and is absent from α 2δ -1−/− brain (second panel; right). The third panel shows the 
DRM marker flotillin-1 (lanes 4–6), and the bottom panel shows RAP, which was also identified by the anti 
LRP1/RAP polyclonal Ab. 5 μ l aliquots of the sucrose gradient fractions are loaded in each lane. (b) Left panel: 
input for IP are peak DRM fractions from α 2δ -1−/− (left lane) and α 2δ -1+/+ (right lane) mouse brains. Right 
panel: IP with unrelated rabbit IgG (lanes 1 and 3) or LRP1 rabbit polyclonal Ab (lanes 2 and 4) from  
α 2δ -1−/− (lanes 1 and 2) and α 2δ -1+/+ (lanes 3 and 4) DRMs. Western blots: top panel: LRP1; middle panel:  
α 2δ -1, showing co-immunoprecipitation of α 2δ -1 (lane 4); bottom panel: PrP (positive control for co-IP, lanes 
2 and 4). Note that the contrast of the western blot shown in the right panel has been enhanced to detect 
low signals. Representative of n = 2 independent experiments. Full blots for all figure parts are shown in 
Supplementary information.
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to the control without RAP (Fig. 6c,d), without significantly affecting the total expression of α 2δ -1Δ C measured 
in permeabilised cells (data not shown). This suggests that the attachment of α 2δ -1Δ C might be mediated by 
an endogenous molecule belonging to the LDL-receptor family, to which α 2δ -1Δ C remains associated through 
the trafficking pathway to the cell surface, such that the binding can be antagonised by RAP, allowing increased 
secretion of α 2δ -1Δ C.
LRP1 and RAP affect the N-glycosylation and proteolytic processing of α2δ-1. Next we examined 
whether LRP1-m4 and RAP would affect the N-glycosylation pattern and proteolytic cleavage of α 2δ -1, in order to 
provide insight into where their interaction occurs. The α 2δ -1 protein goes through a series of post-translational 
processing steps in the ER and Golgi, including N-glycosylation at multiple sites, and proteolytic cleavage of the 
pro-form of α 2δ -1 into α 2 and δ polypeptides (Fig. 7a)48. The core N-linked glycans, added co-translationally to 
Figure 5. RAP promotes the cell surface expression of both LRP1-m4 and α2δ-1, which remain associated 
at the cell surface. (a) tsA-201 cells expressing HA-α 2δ -1, without or with Flag-LRP1-m4 and RAP, were cell 
surface biotinylated and analysed by western blot. Samples were deglycosylated with PNGase-F. Left panel: 
WCL; right panel: cell-surface-biotinylation. Top panel: HA-α 2δ -1 (HA Ab), bottom panel: Flag-LRP1-m4  
(Flag Ab). Both pro-LRP1-m4 and cleaved LBD-LRP1-m4 (indicated) are present on the cell surface.  
(b) Quantification of HA-α 2δ -1 on cell surface expressed as a ratio of biotinylated fraction to input WCL for 
5 experiments, including that shown in (a). The data are normalised to the control in each experiment, in the 
absence of LRP1-m4 or RAP (open bar), LRP1-m4 alone (black bar) and LRP1-m4 plus RAP (red bar). Data 
are mean ± SEM with individual data points, **P < 0.01 ANOVA and Bonferroni post-hoc test. (c) tsA-201 cells 
expressing Flag-LRP1-m4 with HA-α 2δ -1 (left panel) or HA-α 2δ -1 MIDASAAA (right panel), without (left lanes) 
or with RAP (right lanes). Samples were not deglycosylated. Top panel: cell surface-biotinylated α 2δ -1; bottom 
panel WCL. (d) Quantification of α 2δ -1 on cell surface for 5 experiments including that shown in (c), relative 
to control without RAP in each experiment, for LRP1-m4 and WT α 2δ -1 without (black bar), or with RAP (red 
bar), or α 2δ -1 MIDASAAA, without (black and white hatched bar) or with, RAP (red and black hatched bar). 
Data are mean ± SEM with individual data points, *P < 0.05 ANOVA and Bonferroni post-hoc test. (e) tsA-201 
cells were transfected with HA-α 2δ -1 alone (top panel), plus LRP1-m4 (middle panel) or LRP1-m4 and RAP 
(bottom panel) and cell surface-labelled with rat HA Ab (red). The images are merged with DAPI (blue). Scale 
bar 10 μ m. (f) Bar chart (mean ± SEM) showing effect on HA-α 2δ -1 cell surface expression of LRP1-m4 (black 
bar, n = 184 cells); and LRP1-m4 plus RAP (blue bar, n = 149 cells), normalised to control HA-α 2δ -1 alone 
(open bar, n = 120 cells), from n = 2 independent transfections. **P < 0.01, 1-way ANOVA and Bonferroni’s 
post-hoc test. For consistency with the functional experiments shown in Fig. 8, Cav2.2 and β 1b subunits were 
co-transfected in all the experimental conditions (a–f). Full blots in Supplementary information.
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the nascent proteins in the ER, are rich in mannose residues and termed high mannose-type or immature glycans. 
They are subsequently trimmed and modified in the Golgi to mature N-glycans49, although some membrane 
proteins by-pass this route50. The enzyme Endoglycosidase-H (Endo-H) discriminates between the two types 
of N-glycosylation, being able to strip the high mannose N-glycans from proteins, but unable to remove the 
mature N-glycans, formed by processing in the Golgi. The enzyme Peptide-N-Glycosidase-F (PNGase-F) is able 
to remove all types of N-glycosylation from proteins, without discrimination.
Since α 2δ -1 is incompletely proteolytically cleaved when expressed in heterologous systems43, we investigated 
the N-glycosylation pattern of the cleaved α 2-1 and uncleaved α 2δ -1 proteins, as a marker of whether the mature 
cleaved α 2-1 is derived from the ER or Golgi. We found that cleaved α 2-1 is resistant to Endo-H (Fig. 7b; lane 1H, 
closed arrow) but sensitive to PNGase-F (Fig. 7b; lane 1F, closed arrow), showing that it contains mostly mature 
N-glycans, and suggesting that the proteolytic cleavage of α 2δ -1 occurs after trimming of the glycans in the Golgi. 
In line with this result, the uncleaved pro-α 2δ -1 form is mostly sensitive to both Endo-H (Fig. 7b; lane 1H, open 
arrow) and PNG-ase-F (Fig. 7b; lane 1F, open arrow), suggesting that this protein species derives mainly from ER, 
and has not yet been exported through the Golgi, where the N-glycans are modified.
Figure 6. Effect of LRP1-m4 and RAP on secretion of anchorless α2δ-1ΔC. (a) α 2δ -1Δ C-HA was expressed 
in tsA-201 cells either with the empty vector (lane 2) or with increasing concentrations of RAP (lanes 3–5), or 
with Flag-LRP1-m4 (lane 6) or Flag-LRP1-m4 plus RAP (lane 7). Lane 1 shows untransfected cells (U/T). Top 
panel: α 2δ -1Δ C-HA detected in medium (HA Ab). Middle panel: α 2δ -1Δ C-HA in WCL, deglycosylated with 
PNGase-F (α 2δ -1 Ab). Note also the increase in cleaved α 2-1 as RAP is increased (middle panel; lanes 2–5). 
Bottom panel: GAPDH loading control for WCL. (b) Quantification of experiments including that shown in 
(b), of α 2δ -1Δ C-HA secreted into the medium, measured as ratio of WCL α 2δ -1-Δ C, and normalised to control 
without RAP in each experiment (open bar, n = 6), for co-transfection with RAP (0.75 μ g; red bar, n = 6), 
with Flag-LRP1-m4 alone (black bar, n = 5) or LRP1-m4 plus RAP (0.75 μ g; red hatched bar, n = 5). Data are 
mean ± SEM with individual data points, *P = 0.0313, Wilcoxon’s matched pairs signed rank test compared to 
normalised control; †P = 0.0234, paired t test. (c) Non-permeabilised tsA-201 cells, transfected with α 2δ -1Δ 
C-HA, and cell surface-labelled with HA Ab, merged with DAPI staining. Left: control, transfected with α 2δ - 
1Δ C-HA and empty vector; right: α 2δ -1Δ C-HA co-transfected with 0.75 μ g RAP. (d) Bar chart (mean ± SEM) 
showing effect of RAP (red bar, n = 150), normalised to control α 2δ -1Δ C-HA cell surface expression (open 
bar, n = 187), for n = 3 independent experiments. ***P < 0.001, Student’s t test. Full blots for all figure parts are 
shown in Supplementary information.
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Furthermore, co-expression of LRP1-m4 resulted in a reduction of mature Golgi-type N-glycosylation on 
α 2-1 (Fig. 7b, compare lanes 1H and 2H), and reduced α 2δ -1 proteolytic cleavage (Fig. 7b, compare lanes 1F and 
2F, closed arrow), suggesting that it retards forward trafficking of α 2δ -1. In contrast, when RAP was co-expressed 
with LRP1-m4, it antagonised this effect, and increased both mature N-linked glycosylation (Fig. 7b, lane 3H) and 
the cleavage of α 2δ -1 (Fig. 7b; compare lanes 3F and 2F). Quantification of proteolytic cleavage of α 2δ -1 showed 
that the additional presence of RAP increased α 2δ -1 cleavage ~2-fold compared to LRP1-m4 alone (Fig. 7c). This 
is in agreement with the hypothesis that in the absence of RAP, an interaction between LRP1 and α 2δ -1 early 
after their translation results in ER retention; this is antagonised by RAP, allowing forward trafficking. It is likely 
that RAP, by increasing the folding of LRP1, allows trafficking of both LRP1 and α 2δ -1 to the Golgi. Our results 
suggest that proteolytic cleavage of α 2δ -1 occurs in Golgi or post-Golgi compartments. It is also likely that α 2δ -1 
is trafficked in a complex with LRP1-m4, as we still detected interaction of LRP1-m4 with α 2δ -1 on the cell sur-
face (see Fig. 2c). This provides further evidence for the dual role of RAP in antagonising premature interaction 
between LRP1 and its ligands in the ER, as well as in trafficking of both LRP1 and its ligands.
Effect of LRP1 and RAP on calcium currents and cell surface expression of CaV2.2 and α2δ-1. 
We then examined whether the effects of LRP1-m4 and RAP on trafficking and proteolytic processing of α 2δ -1 
Figure 7. Effects of RAP and LRP1-m4 on α2δ-1 subunit trafficking impacts their glycosylation pattern 
and post-translational proteolytic cleavage. (a) Schematic representation of the different species of α 2δ -1 
N-glycosylation associated with proteolytic processing, indicating that the cleaved α 2-1 is resistant to Endo-H 
treatment after its processing in the Golgi. (b) Western blot analysis: WCL from tsA-201 cells expressing HA- 
α 2δ -1 either alone (lane 1), with Flag-LRP1-m4 (lane 2) or with Flag-LRP1-m4 and 1 μ g RAP (lane 3). Top 
panel: α 2δ -1 (α 2-1 mAb), bottom panel, reblot for Akt loading control. Left panel shows glycosylated α 2δ -1 
(lanes 1–3), which does not resolve the different species of α 2δ -1. Endo-H treatment (middle panel; lanes 1H-
3H), targeting only the high–mannose (ER–associated), but not the complex (Golgi–associated) N-glycans, 
shows that cleaved α 2-1 is resistant to Endo-H (α 2-1* species; solid arrowhead on left), whereas uncleaved 
pro-α 2δ -1 is sensitive to Endo-H (α 2δ -1 species; open arrowhead on left). White arrows on blot shows a minor 
fraction of the uncleaved pro-α 2δ -1, which is Endo-H resistant. Note that Endo-H-resistant (Golgi-associated) 
species of α 2δ -1 are reduced upon co-expression of Flag-LRP1-m4 (middle panel; lane 2H), which is reversed by 
co-expression of RAP (middle panel; lane 3H). PNGase-F treatment (right panel; lanes 1F-3F) caused removal 
of all types of N-glycans from both cleaved α 2-1 and uncleaved α 2δ -1 (arrows on right). Note that cleavage 
of α 2-1 is reduced upon co-expression of Flag-LRP1-m4, and this is reversed by co-expression of RAP (α 2-1 
species; compare lanes 2F and 3F). Representative of n = 2 experiments. (c) Quantification of α 2δ -1 proteolytic 
processing expressed as a ratio of cleaved α 2-1 to total α 2δ -1 (cleaved + uncleaved) in PNGase-F deglycosylated 
WCL, normalised to control conditions (open bar), in the presence of LRP1-m4 (black bar) or LRP1-m4 plus 
1 μ g or 2 μ g RAP cDNA (blue and red bars respectively). Data are mean ± SEM with individual data points for 
n = 3 independent experiments. **P < 0.01, *P < 0.05, 1-way ANOVA and Bonferroni’s post-hoc test. Full blots 
for all figure parts are shown in Supplementary information.
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would translate into effects on calcium currents. CaV2.2 was co-transfected with β 1b and α 2δ -1, with either a con-
trol cDNA, LRP1-m4 alone or LRP1-m4 plus RAP. The peak IBa current density in the presence of LRP1-m4 and 
RAP was 2.6-fold greater than in the absence of RAP, in agreement with the general hypothesis outlined above 
(Fig. 8a,b,c). Similar results were obtained using either an irrelevant protein vector or empty pcDNA3 vector in 
the control condition (data not shown).
Furthermore RAP alone produced a small increase in calcium currents, increasing the peak IBa by 36% 
(Fig. 9a,b), and increased the amount of CaV2.2 on the cell surface, determined by α -bungarotoxin cell surface 
labelling of BBS-tagged CaV2.2 by 56.9% for 0.75 μ g RAP (Fig. 9c,d)46. Moreover, RAP alone also increased the cell 
surface expression of α 2δ -1, determined by cell surface biotinylation, (Fig. 9e, compare lane 1 with lanes 3 and 4; 
quantified in Fig. 9f). The mean increase was 51.8% for 0.75 μ g RAP. These effects of RAP are likely to be mediated 
either via an influence on endogenous LRP1 or another member of this family, and suggest that endogenous RAP 
may be limiting in these circumstances.
Discussion
LRP proteins are widely recognised to be involved in trafficking and endocytosis of many protein ligands21,51, and 
loss of LRP1 in the central nervous system results in impaired synaptic function29,30. Furthermore, other LRP 
family members are also involved in a number of signalling pathways; for example LRP5/6 are co-receptors with 
the G-protein coupled receptor, frizzled, for Wnt signalling22. Here we show that the calcium channel auxiliary 
subunit α 2δ -1 is a ligand for LRP1, which, when combined with its chaperone protein RAP, promotes the traffick-
ing, cell surface expression, mature glycosylation and proteolytic cleavage of α 2δ -1. We also provide evidence that 
LRP1 remains associated with α 2δ -1 on the cell surface in the presence of RAP. The α 2δ -1 subunit associates with 
CaV1 and CaV2 calcium channels, to promote their trafficking and voltage-dependent activation6. We find here 
that the LRP1/RAP combination also promotes functional expression of the neuronal (N-type) CaV2.2 channels, 
in terms of both cell surface expression and increased calcium currents. We have recently shown that proteolytic 
processing of α 2δ into α 2 and δ is essential for this auxiliary subunit to enhance currents through CaV2.2 chan-
nels48, and we find here that proteolytic cleavage of α 2δ -1 is increased by LRP1/RAP, which is likely to contribute 
to their effect on calcium currents.
CACNA2D1, the gene encoding α 2δ -1, is one of many genes whose expression is altered in sensory DRG neu-
rons following peripheral nerve damage leading to neuropathic pain15,52,53. In contrast RAP is down-regulated 
Figure 8. Co-expression of RAP with LRP1-m4 increases CaV2.2 current density. (a) Example IBa current 
traces evoked by voltage steps from a holding potential of − 80 mV to between − 15 and + 15 mV for tsA-201 cells 
transfected with CaV2.2/β 1b/α 2δ -1 and control cDNA (top), LRP1-m4 (middle) or LRP1-m4/RAP (bottom). The 
charge carrier is 1 mM Ba2+. The scale bars refer to all traces. (b) Mean (± SEM) IV curves for control cells (open 
circles, n = 11), LRP1-m4-transfected cells (black circles, n = 10), or LRP1-m4/RAP-transfected cells (red circles, 
n = 10), from 3 independent experiments. (c) Comparison of peak IBa density at + 10 mV (mean ± SEM with 
individual data points) for control cells (open bar), LRP1-m4-transfected cells (black bar) and LRP1-m4/RAP-
transfected cells (red bar). **P < 0.01, 1-way ANOVA and Bonferroni’s post-hoc test.
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in DRG neurons following sensory nerve injury36. The consequences of this for α 2δ -1 trafficking and calcium 
channel function might be to retain some of the increased α 2δ -1 in the ER because of premature interaction with 
LRP1. Relevant to this, we observed a substantial amount of α 2δ -1 in the ER within rat DRG cell bodies following 
spinal nerve ligation15, and also observed uncleaved α 2δ -1 in DRG somata48.
Of interest, the LRP1 gene has recently been identified as a susceptibility locus associated with common pain-
ful migraine54, and LRP1 has also been linked to the survival of Schwann cells and signalling in neuropathic 
pain55. Painful nerve injury also results in up-regulation of the extracellular matrix protein thrombospondin-456. 
Thrombospondin family members are known LRP1 interacting proteins32. Indeed, we have previously confirmed 
this interaction, showing thrombospondin-4 to interact with the LRP1 mini-receptors used in the present study40. 
Thrombospondins have also been identified as binding partners for α 2δ -1, by co-immunoprecipitation19. This 
interaction was found to be disrupted by gabapentin; and it was suggested that this might mediate a therapeu-
tic action of gabapentin via inhibition of synaptogenesis19. In contrast, we found that there was no detectable 
Figure 9. Expression of RAP alone enhances CaV2.2 current density and CaV2.2 cell surface expression.  
(a) Mean (± SEM) IV curves for IBa recorded from tsA-201 cells transfected with CaV2.2/β 1b/α 2δ -1 (normalised 
to mean controls within each experiment), for control cells (open circles, n = 23) and cells transfected 
additionally with RAP (red circles, n = 25), from 2 independent experiments. The charge carrier is 1 mM Ba2+. 
(b) Comparison of normalised peak IBa density at + 10 mV (mean ± SEM with individual data points) for 
control cells (open bar) and RAP-transfected cells (red bar). One data point was removed as an outlier (4.1-fold 
greater than the mean, P < 0.01 Grubb’s test). Statistical difference, Student’s t test: *P = 0.0193. (c) tsA-201 cells 
transfected with BBS-CaV2.2/β 1b/HA-α 2δ -1 and cell-surface labelled with α -bungarotoxin AF-488. Top panel: 
control, transfected with empty vector; middle and bottom panels: co-transfected with 0.75 and 1.5 μ g RAP, 
respectively. Scale bar 10 μ m. (d) Bar chart (mean ± SEM) quantifying effect of the two RAP concentrations 
on cell surface BBS-CaV2.2 signal (blue bar, 0.75 μ g RAP, n = 246; red bar, 1.5 μ g RAP, n = 285), normalised 
to control BBS-CaV2.2 cell surface expression (open bar, n = 176), from three independent transfections, 
including that shown in (c). ****P < 0.0001, 1-way ANOVA and Bonferroni’s post-hoc test. (e) Example western 
blot from tsA-201 cells transfected with HA-α 2δ -1, without RAP (lane 1) or with RAP (0.5, 0.75 and 1.5 μ g, 
lanes 2–4), showing WCL (left panel) and corresponding cell surface biotinylation (right panel) for HA-α 2δ -1. 
Cav2.2 and β 1b subunits were co-transfected for consistency with the experiments shown in parts (a–d) of this 
figure, but were not visualised by antibody staining. (f) Bar chart (mean ± SEM) and individual data points, 
for 0.75 μ g (blue bar, ○, n = 6) and 1.5 μ g RAP (red bar, ∆,  n = 3)), showing effect of RAP on α 2δ -1 cell surface 
expression determined by biotinylation from experiments including that in (e) normalised to control (open 
bar). *P = 0.0313, Wilcoxon’s matched pairs signed rank test. Combining all data, for both RAP concentrations, 
P < 0.0039 compared to control. Full blots for all figure parts are shown in Supplementary information.
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interaction of the two proteins on the cell surface of transfected cells40. However the affinity of [3H]-gabapentin 
binding to α 2δ -1 was reduced by co-expression of thrombospondin-4; therefore we concluded there could be a 
weak interaction between co-expressed α 2δ -1 and thrombospondin-4 in membranes derived from intracellular 
compartments. In the present study we have shown that LRP1 interacts with α 2δ -1, both by immunoprecipitation 
and by pull-down with purified LRP1 mini-receptors. Therefore it is possible, since LRP1 has multiple LBDs, 
that LRP1 (or a related family member) could contribute to bridging an indirect interaction between α 2δ -1 and 
thrombospondins, or indeed between PrP and α 2δ -157.
Although LRP1 is not primarily a DRM-associated protein, it has previously been observed in DRMs from 
some cell types58. Furthermore, it does interact with some DRM-associated proteins, for example with PrP25, 
which has been found to result in signalling in specific DRM domains58,59. LRP1 also affects PrP endocytosis in 
a RAP-dependent manner25. We find here that a small proportion of LRP1 is present in mouse brain DRMs, and 
here it co-immunoprecipitates a comparable fraction of α 2δ -1 and PrP, both being established DRM residents. 
The relatively small co-immunoprecipitated fraction relative to the total α 2δ -1 and PrP in DRMs is in line with 
the partial partitioning of LRP1 into DRMs.
LRP1 is known to be recruited to caveolae59, and to be involved in endocytosis60. Whether LRP1 and RAP 
also influence α 2δ -1 endocytosis, in the same way as for PrP, and whether the same LRP1 molecule can bind both 
α 2δ -1 and PrP ligands occupying different sites, remains to be determined in future studies.
LRP1 binds multiple ligands37, including von Willebrand factor61, and this contributes to the clearance of von 
Willebrand factor which is internalised from blood plasma by macrophages62. LRP1 also binds to the inserted 
VWA domain in α Mβ 2 integrin51. A poly-basic motif at the start of the VWA domain is implicated in this bind-
ing, rather than a direct interaction with the VWA domain MIDAS motif. It is of interest that one of the key 
motifs mediating gabapentin binding to α 2δ -1 and α 2δ -2 is a basic triple arginine sequence, just prior to its VWA 
domain8,12,63. In the present study we found that the number of gabapentin binding sites (Bmax) associated with 
α 2δ -1 was markedly reduced by co-expression of LRP1. It is thus possible that LRP1 binding to α 2δ -1 involves the 
gabapentin binding pocket motif, thus occluding the gabapentin binding site.
Despite our evidence that endogenous LRP1 is a good candidate for interaction with α 2δ -1, both during traf-
ficking and on the cell surface, at this point we cannot exclude other endogenous members of LDL–receptor 
family of proteins, such as LRP5/6 which also interact with RAP64, and are involved in Wnt signalling22. It will be 
of interest in the future to determine whether these LRP family members interact with α 2δ proteins.
Methods
Molecular biology. The cDNAs used were: rat α 2δ -1 (M86621), rabbit CaV2.2 (D14157 without 3′ UTR), 
and rat β 1b (X61394). In some experiments CaV2.2 was used with an extracellular BBS tag (BBS-CaV2.2)46. Other 
α 2δ -1 constructs used were α 2δ -1-Δ C-HA (C-terminal HA tag)43 and HA-α 2δ -1 (HA-tag sequence YPYDVPDYA 
inserted between Asn-549 and Asp-550)43. These cDNAs were in the pMT2 and pCDNA3 vectors for expression 
in tsA-201 cells. LRP1 mini-receptors m1-m4 cDNAs in pcDNA339 and RAP pcDNA3 were gifts from Dr. Guojun 
Bu (Washington University, St Louis, USA). A triple Flag tag (22 amino acids) was inserted in place of the orig-
inal HA tag in the LRP1 mini-receptor constructs, between amino acids 24 and 2540. Other cDNAs used were 
β 1b-GFP65, P2 × 2K69A (gift from Prof. R. A. North, Manchester University), Kir2.1AAA (gift from Prof. A Tinker, 
William Harvey Research Institute, Queen Mary University of London) and CD8 transfection marker.
Antibodies and other materials. The α 2δ -1 antibody used is a mouse monoclonal against the α 2-1 moiety 
(Sigma-Aldrich); the epitope is identified in ref. 46. Other antibodies used were anti-HA (rat monoclonal, Roche, 
used for immunocytochemistry), anti-HA (rabbit polyclonal, Sigma, used for most western blots), anti-GAPDH 
(mouse monoclonal, Ambion), anti-flotillin-1 (mouse monoclonal, BD Biosciences), anti-Akt/PKB (rabbit pol-
yclonal, Cell Signaling Technologies); anti-M2 Flag (Sigma), polyclonal anti-LRP1 antibody raised against puri-
fied LRP1, which also recognises RAP (gift and personal communication from Dr. S. Moestrup, Department of 
Biomedicine, Aarhus University, Denmark) and anti-PrP (3F4 epitope)57 (gift from Dr. Roberto Chiesa). For 
immunocytochemistry, secondary Abs (1:500) used were anti-rat-Alexa Fluor 594 or anti-rat-fluorescein isothi-
ocyanate (FITC) (Sigma-Aldrich).
Cell culture and transfection. The tsA-201 cells (European Collection of Authenticated Cell Cultures), 
tested to be mycoplasma-free, were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% foetal bovine serum (FBS), 1 unit/ml penicillin, 1 μ g/ml streptomycin and 1% GlutaMAX (Life 
Technologies, Waltham, MA). They were plated onto cell culture flasks, coverslips or glass-bottomed dishes 
(MatTek Corporation, Ashland, MA), coated with poly-L-lysine, and cultured in a 5% CO2 incubator at 37 °C. 
Cells were transfected using Fugene6 (Promega, Fitchburg, WI), according to the manufacturer’s protocol. For 
biochemical experiments cells were harvested 48 h after transfection, by washing cells in phosphate-buffered 
saline (PBS, pH 7.4, Sigma), detaching with a cell scraper into PBS, and pelleting by centrifugation at 1,000 × g.
For electrophysiology the DNA ratios for CaV2.2/β 1b/α 2δ -1 were maintained constant within each set of 
experiments, usually at 3:2:2, and either empty vector or a non-functional membrane protein P2 × 2K69A or 
Kir2.1AAA were used in controls in place of LRP1-m4 or RAP, in order to maintain constant the total amount 
of cDNA transfected In some experiments β 1b-GFP was used in place of β 1b, to detect transfected cells. 
Site-directed mutagenesis was carried out using standard procedures, and all subcloning and mutations con-
firmed by sequencing.
Transgenic mice. Conventional α 2δ -1 knockout (α 2δ -1−/−) mice on C57Bl/6 background were used66–68. 
Mice were housed in groups of no more than 5 on a 12 h:12 h light dark cycle; food and water were available ad 
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libitum. Brains were obtained from male 10-week old α 2δ -1−/− mice and α 2δ -1+/+ littermates, obtained by breed-
ing from heterozygotes, during the course of a previous study67, and frozen at − 80 °C until use. All experimental 
methods, procedures and protocols relating to breeding and obtaining tissue from these mice were approved by 
the UK Home Office and by the UCL local ethical committee. All methods were performed in accordance with 
the relevant guidelines and regulations.
Western blotting. Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) was carried 
out as previously described43. The following secondary Abs were used for western blotting: goat anti-rabbit, goat 
anti-rat and goat anti-mouse Abs coupled to horseradish peroxidase (HRP) (Biorad). The signal was obtained by 
HRP reaction with fluorescent product (ECL 2; Thermo Scientific), and membranes were scanned on a Typhoon 
9410 phosphorimager (GE Healthcare). Full blots for all figures are shown in Supplementary information.
Preparation of Triton X-100-insoluble DRMs and co-immunoprecipitation. The protocol was 
similar to that described previously7,43. All steps were performed on ice. Whole brains (without cerebellum) 
from WT and α 2δ -1−/− mice were used as the starting material. Tissue was homogenised using a Teflon homog-
eniser in Mes-buffered saline (MBS), containing 25 mM Mes (pH 6.5), 150 mM NaCl and protease inhibitors 
(PI, cOmplete, Roche; used according to manufacturer’s instructions), containing 1% (v/v) Triton X-100 (Thermo 
Scientific), and left on ice for 1 h. The sample was then supplemented with 90% sucrose to 45% final concentration 
and overlaid with 10 ml of discontinuous sucrose gradient, consisting of 35% (w/v) sucrose in MBS (5 ml) and 5% 
(w/v) sucrose in MBS (5 ml), centrifuged at 138,000 × g for 18 h at 4 °C (Beckman SW40 rotor). Fractions (1 ml) 
were subsequently harvested from the top to the bottom of the tube, and DRM fractions from the gradient were 
washed free of sucrose by dilution in 25 volumes of ice-cold PBS, and ultracentrifugation (150,000 × g for 1 h at 
4 °C) to pellet the DRMs to be used for co-immunoprecipitation as described below.
Cell surface biotinylation, cell lysis, deglycosylation and immunoblotting. The procedures were 
modified from those described previously7. Briefly, 48 h after transfection, tsA-201 cells were incubated for 30 min 
at room temperature with 0.5 mg/ml EZ-link Sulfo-NHS-LC-Biotin (Thermo Scientific) in PBS, and the reac-
tion was quenched with 200 mM glycine. The cells were lysed for 45 min on ice in PBS, containing 1% Igepal; 
0.1% SDS and PI. The WCL was then centrifuged at 20,000 × g at 4 °C for 20 min, and the pellet discarded. The 
supernatant was assayed for total protein (Bradford assay, Biorad). Immunoblot analysis was performed essen-
tially as described previously43. Cleared WCL corresponding to 20–40 μ g total protein was diluted with Laemmli 
sample buffer7, supplemented with 100 mM dithiothreitol (DTT), incubated at 60 °C for 10 min and resolved by 
SDS-PAGE and western blotting. Biotinylated lysates (adjusted to between 0.5 and 1 mg/ml total protein concen-
tration) were applied to 40 μ l prewashed streptavidin-agarose beads (Thermo Scientific) and rotated overnight at 
4 °C. The beads were then washed 3 times with PBS containing 0.1% Igepal and, when required, the streptavidin 
beads were re-suspended in PNGase-F buffer (containing PBS, supplemented with 75 mM β -mercaptoethanol, 
1% Igepal, 0.1% SDS, and PI) and deglycosylated for 3 h at 37 °C with PNGase-F (Roche Applied Science). When 
required, WCL were deglycosylated with PNGase-F under identical conditions described above or with Endo-H 
(NEB) following the manufacturer’s instructions. The samples were then resuspended in an equal volume of 
2 × Laemmli buffer with 100 mM DTT, followed by 10 min incubation at 60 °C, prior to analysis by SDS-PAGE 
and western blotting.
Co-immunoprecipitation. The assay was done as previously described with modifications48. Cell pel-
lets were resuspended in co-immunoprecipitation buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% Igepal, 0.5% 
Na deoxycholate, 0.1% SDS, 1 mM MgCl2, 1 mM CaCl2, supplemented with EDTA-free PI), homogenised by 
5 × passes through a 23 gauge syringe and 5 s sonication at 20,000 Hz, and then incubated for 1 h on ice. Insoluble 
material was removed by centrifugation at 20,000 × g for 30 min at 4 °C. The supernatant was incubated with 
2 μ g/ml of anti-M2-Flag antibody overnight at 4 °C with constant rotation. 30 μ l prewashed A/G PLUS Agarose 
beads (Santa Cruz) were added to each tube and further rotated for 2 h at 4 °C. The beads were then pelleted 
by 500 × g centrifugation at 4 °C and washed twice with a co-immunoprecipitation wash high detergent buffer 
(1% Igepal, 20 mM Tris pH 7.4, 150 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, with EDTA-free PI), twice with 
co-immunoprecipitation wash high salt buffer (0.1% Igepal, 20 mM Tris pH 7.4, 500 mM NaCl, with EDTA-free 
PI), and twice with a low salt co-immunoprecipitation wash (0.1% Igepal, 20 mM Tris pH 7.4, with EDTA-free 
PI). Native LRP1 and α 2δ were precipitated from whole brain DRMs concentrated as described above. DRMs were 
resuspended in a buffer consisting of 20 mM Tris pH 7.4, 150 mM NaCl, 1% 1-O-Octyl-β -D-glucopyranoside 
(OG; Sigma) and PI; then sonicated for 10 s at 20,000 Hz, rotated at 4 °C for 1 h and centrifuged at 20,000 × g 
at 4 °C. The supernatants were assayed for total protein, concentrations were equalised, and 20 μ g/ml of rab-
bit anti-LRP1 or 20 μ g/ml of rabbit non-specific IgG were added to the samples and rotated overnight at 4 °C. 
The samples were washed four times in the same buffer, but supplemented with 0.2% OG. The beads, with 
co-immunoprecipitated proteins, were resuspended in an equal volume of 2 × Laemmli buffer with 100 mM 
DTT, and analysed by SDS-PAGE and western blotting, together with aliquots of the initial WCL prior to 
co-immunoprecipitation.
Cell surface co-immunoprecipitation. The protocol was performed as described previously25, with mod-
ifications. 48 h after transfection, tsA-201 cells were rinsed twice with PBS and incubated with gentle rocking at 
4 °C for 45 min with 4 μ g/ml monoclonal anti-M2-Flag antibody, diluted in a cold serum-free DMEM, supple-
mented with 10 mM HEPES pH 7.4. Cells were harvested and all subsequent procedures were performed on 
ice. The cell pellet was resuspended in co-immunoprecipitation buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% 
Igepal, 0.5% Na deoxycholate, 0.1% SDS, 1 mM MgCl2, 1 mM CaCl2, with EDTA-free PI), homogenised as in 
co-immunoprecipitation, and incubated for 1 h on ice followed by centrifugation at 1000 × g for 5 min at 4 °C. 
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The supernatants were collected and assayed for total protein (Bradford assay) and the concentration was adjusted 
to 1 mg/ml with co-immunoprecipitation buffer. 40 μ l pre-washed A/G PLUS-Agarose beads (Santa Cruz) were 
added to each sample followed by rotation for 1 h at 4 °C. The beads were then pelleted by centrifugation (500 × g; 
4 °C), washed twice with co-immunoprecipitation wash buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 0.5% Igepal, 
1 mM MgCl2, 1 mM CaCl2, with PI) and the sample was resupended in an equal volume of 2 × Laemmli buffer 
with 100 mM DTT, and analysed by SDS-PAGE and western blotting.
Affinity purification of secreted α2δ-1ΔC-HA from conditioned media. tsA-201 cells were trans-
fected with α 2δ -1Δ C-HA and incubated for 48 h in a 5% CO2 incubator at 37 °C in DMEM medium supple-
mented with 2% FBS, 1 unit/ml penicillin, 1 μ g/ml streptomycin and 1% GlutaMAX. The conditioned medium 
from 6 flasks was pooled, filtered (0.2 μ m membrane pore size) and concentrated (x 40 fold) on a 10 kDa Nominal 
Molecular Weight Limit (NMWL) Amicon column (Merck Millipore) following the manufacturer’s instructions. 
The concentrated material was supplemented with 20 mM HEPES pH 7.4 and OG (Sigma) to 0.2% final concen-
tration, and applied to a 1 ml agarose-anti-HA antibody column (Sigma), pre-equilibrated in wash buffer (20 mM 
HEPES pH 7.4, 200 mM NaCl, 0.2% OG), and rotated for 1 h at 20 °C. The column was washed extensively in wash 
buffer, and bound proteins were then eluted with 3 ml 100 mM glycine pH 2.5 in 0.5 ml fractions into tubes con-
taining 50 μ l 1 M HEPES pH 7.4 for immediate neutralisation. The eluates were applied to 3 ml Slide-A-Lyzer™ 
Dialysis Cassettes (3.5 K MWCO, Thermo Fisher Scientific) and dialysed overnight at 4 °C against 2 L of PBS, pH 
7.4. Then aliquots of purified protein were analysed by SDS-PAGE and western blotting with anti-HA antibody, 
and on a silver stained gel, on which the concentration was estimated by running BSA standards of known con-
centration (not shown).
Dot blot binding assay. The assay was a modification of that described previously44. 0.2 μ g of purified 
Ligand binding cluster-II of LRP1 Recombinant Human protein (LRP1-m2 LBD; Thermo Fisher Scientific; 
dissolved to 0.1 mg/ml) or 0.2 μ g BSA as negative control were immobilised on dry nitrocellulose membranes 
(Biorad). Membranes were then blocked for 1 h at 20 °C with dot blot buffer (PBS supplemented with 0.5% Igepal, 
3% BSA, 1 mM MgCl2, and 1 mM CaCl2). Purified α 2δ -1Δ C-HA was then diluted to 50 nM in dot blot buffer, 
and applied to the membranes for 1 h at 20 °C with gentle rocking. This was followed by three washes with dot 
blot wash buffer (dot blot buffer without BSA), and incubated for 1 h at 20 °C with anti-HA antibody diluted 
1:1000 in dot blot buffer, three additional washes with dot blot wash buffer, and 30 min incubation at 20 °C with 
anti-rabbit-HRP diluted 1:3000 in dot blot buffer. After three final washes with dot blot wash buffer and a final 
wash with dot blot wash buffer without detergent, the proteins with bound antibodies were visualised with ECL 2.
In vitro binding technique. tsA-201 cells were either not transfected or transfected separately with cDNA 
encoding HA-α 2δ -1 or Flag-LRP1-m4/RAP (cDNA ratio 10:1). Cell pellets were homogenised at 4 °C in binding 
buffer (PBS supplemented with 25 mM sucrose, 1.5 mM CaCl2, 1 mM MgCl2, EDTA-free PI, and 0.5% Igepal) 
as for co-immunoprecipitation, and incubated on ice for 1 h. The lysates were cleared by 20,000 × g centrifu-
gation at 4 °C and supernatants were collected and assayed for total protein (Bradford assay). The lysates from 
Flag-LRP1-m4/RAP and untransfected cells were rotated overnight at 4 °C with 10 μ g/ml anti-M2-Flag antibody, 
then 50 μ l of beads (prewashed in binding buffer) were added, and the sample was rotated for 2 h at 4 °C followed 
by 3 × washes with wash buffer (binding buffer supplemented with 0.1% Igepal). HA-α 2δ -1 lysate was then equil-
ibrated to 20 °C, and applied to the beads, and the samples were incubated for 2 h at 20 °C followed by 3 × washes 
with wash buffer and elution by heating in 2 × Laemmli buffer with 100 mM DTT prior to analysis by SDS-PAGE 
and western blotting.
Immunocytochemistry, imaging and analysis. The procedure in tsA-201 cells was performed essen-
tially as described previously with minor modifications7,43. Briefly, 48 h post-transfection the cells were fixed 
with 4% paraformaldehyde (PFA) in PBS at 20 °C for 5 min, and then incubated in PBS for 15 min. Blocking was 
performed for 1 h at 20 °C in PBS containing 20% goat serum and 5% bovine serum albumen (BSA). The primary 
antibody was then applied (diluted in PBS with10% goat serum and 2.5% BSA) overnight at 4 °C. The second-
ary antibody was applied (1:500 dilution in PBS, containing 2.5% BSA and 10% goat serum) at 20 °C for 1 h. In 
live-labelling experiments, cells expressing BBS-CaV2.2 together with α 2δ -1 and β 1b were washed with Krebs 
Ringer HEPES (KRH) buffer, labelled with α -bungarotoxin (BTX)-AF 488 (Invitrogen; 1:100 in KRH buffer) 
at 17 °C for 30 min, then washed with KRH and fixed as described above46. Cell nuclei were stained with 0.5 μ M 
4′,6′-diamidino-2-phenylindole (DAPI) in PBS for 5 min. The coverslips were mounted onto glass slides using 
VECTASHIELD® mounting medium (Vector Laboratories, Peterborough, UK).
Imaging was performed on a Zeiss LSM 780 confocal microscope as described elsewhere46. Images were 
obtained at fixed microscope settings for all experimental conditions of each experiment. Images (1024 × 1024 
pixels) of tsA-201 cells were obtained using a 40× or 63× objective and an optical section of 0.8–1 μ m. Every 
cell identified as transfected was included in the measurements, to ensure lack of bias. Images were analysed 
using imageJ (imagej.net) using a modification of the procedure described previously7,43. Surface labelling in 
non-permeabilised cells was measured using the freehand line tool and manually tracing the surface of the cell. 
The value of the mean pixel intensity in different channels was measured separately and background was sub-
tracted by measuring the intensity of an imaged area without transfected cells. All data were then normalised to 
the appropriate positive control for each experiment before combining experiments.
Electrophysiology. Calcium channel currents in transfected tsA-201 cells were investigated by whole cell 
patch clamp recording, essentially as described previously48. Cells were selected either using co-transfection 
with CD8 antigen, or by using β 1b-GFP65, with essentially equivalent results, which were combined. The patch 
pipette solution contained in mM: Cs-aspartate, 140; EGTA, 5; MgCl2, 2; CaCl2, 0.1; K2ATP, 2; Hepes, 10; pH 7.2, 
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310 mOsm with sucrose. The external solution for recording Ba2+ currents contained in mM: tetraethylammo-
nium (TEA) Br, 160; KCl, 3; NaHCO3, 1.0; MgCl2, 1.0; Hepes, 10; glucose, 4; BaCl2, 1, pH 7.4, 320 mosM with 
sucrose. Unless otherwise stated, 1 mM extracellular Ba2+ was the charge carrier. An Axopatch 1D or Axon 200B 
amplifier was used, with pipettes of resistance 2–4 MΩ. Whole cell voltage-clamp recordings were sampled at 
10 kHz frequency, filtered at 2 kHz and digitized at 1 kHz. 70–80% series resistance compensation was applied and 
all recorded currents were leak subtracted using P/8 protocol. Membrane potential was held at − 80 mV. Analysis 
was performed using Pclamp 9 (Molecular Devices) and Origin 10 (Microcal Origin, Northampton, MA).
[3H] gabapentin binding assay. Binding of [3H]-gabapentin to membranes from tsA-201 cells was carried 
out essentially as previously described40, in a final volume of 250 μ l at room temperature for 45 min. The cDNA 
for Kir2.1AAA was used in control transfections to maintain the amount of total cDNA constant, and in order to 
have cells expressing similar amounts of protein under the experimental conditions used. Western blots for α 2δ -1 
expression were quantified for every experiment to ensure similar expression levels. Membrane fractions (60 μ g 
of protein per tube) were incubated with various concentrations of [3H]-gabapentin (specific activity 36 Ci/mmol, 
American Radiolabeled Chemicals, St. Louis, MO, USA) in 10 mM HEPES/KOH pH 7.4, then rapidly filtered 
through GF/B filters, pre-soaked with 0.3% polyethyleneimine. Filters were washed three times with 3 ml ice-cold 
50 mM Tris/HCl, pH 7.4 and counted on a scintillation counter. Concentrations of [3H]-gabapentin greater than 
50 nM were achieved by adding non-radioactive gabapentin and correcting the specific binding by the dilution 
factor4. Non-specific binding was determined in the presence of 20 μ M non-radioactive gabapentin. Data points 
were determined in triplicate, and data were analysed by fitting specific binding to the Hill equation40.
Data analysis. Data are given as mean ± SEM, with individual data points if < 30. Statistical comparisons 
were performed using either Student’s t test, paired t test, Wilcoxon’s matched pairs signed rank test, ANOVA with 
appropriate post-hoc test, as stated, using Graphpad Prism 5.
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